Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 13 2025
0mins
Should l Buy ?
Source: Globenewswire
Clinical Study Progress: Vivani Medical's LIBERATE-1 study on a miniature GLP-1 implant for weight management has successfully enrolled participants, with all insertions completed and top-line results expected in mid-2025.
Financial Developments: The company secured $3 million in new equity financing, alongside previously reported funding, to support its operations through mid-2026, while also planning to spin off its Cortigent division into an independent entity.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
